Keyword: Sanofi

Chemistry & Life Sciences

The Future of mRNA Technology

20.03.2024 -

mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...

News

2024 Guidance Suspended: API Production Paused in Brindisi, Italy

19.03.2024 -

EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.

News

Partex and Sanofi Partner for AI-Enhanced Dossier Improvement

18.03.2024 -

Partex Group, an AI-driven drug discovery company, today announces a collaboration with global pharmaceutical company Sanofi, aimed at using Partex’s AI technology to...

News

SK Bioscience to Expand South-Korean Vaccine Production Capacity

11.03.2024 -

South Korea-based contract development and manufacturing organization (CDMO) SK Bioscience has broken ground on an approximately 4,200 m2 expansion of its L House vaccine...

News

Sanofi to Acquire Inhibrx for $1.7 Billion

23.01.2024 -

Sanofi agreed to acquire biopharmaceutical company Inhibrx following the spin-off of non-INBRX-101 assets into New Inhibrx for approximately $1.7 billion and will also...

News

SK Bioscience to Expand Production Capacity for Pneumococcal Vaccine in Korea

04.12.2023 -

South Korea-based contract development and manufacturing organization (CDMO) SK Bioscience wants to expand its vaccine manufacturing plant located in Andong, South Korea...

News

Sanofi Enters into Partnerships with Janssen and Teva

04.10.2023 -

Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize the vaccine candidate for...

Markets & Companies

Navigating Uncertainty in the Biopharma Market

17.05.2023 -

Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...